Author

Xiaowei Xu

Observed name: Xu, Xiaowei

Institutions: Hunan University of Traditional Chinese Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College

Observed institutions: Hunan University of Traditional Chinese Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College

OpenAlex ID: A5121840694

An updated cost-effectiveness analysis of osimertinib versus placebo in resected EGFR-mutated non-small cell lung cancer: the perspective of the United States

2026 · Fangping Chen, Xiaowei Xu, et al. · BMC Health Services Research · 2

An auditable conditional-strategy framework for open-ended decision-making in complex lung cancer

2026 · Wang, Daoyun, Huang, Zhicheng, et al. · arXiv (Cornell University)

Works count: 2

Citation count: 2

H-index: 1

I10-index: